Breaking a sweat: Using chloride in sweat to help diagnose cystic fibrosis Dr. Kamal Kant Kohli21 Aug 2025 8:30 PM ISTSweat does more than just cool down an overheating body. Measuring the chemical makeup of an individual's sweat-specifically the levels of chloride, a...
Levodropropizine A Valuable Peripheral Anti-tussive for Dry Cough in Primary Care Settings: Latest Indian Clinicians' Review Dr. Garima Soni21 Aug 2025 12:25 PM ISTIndia: Levodropropizine, a nonopioid peripheral antitussive, may be a valuable agent for providing symptomatic relief in nonproductive, dry cough in...
Increase in blood SIRI levels elevates the risk of COPD: Study Jacinthlyn Sylvia20 Aug 2025 9:30 PM ISTA new study published in the International Journal of Chronic Obstructive Pulmonary Disease showed a non-linear association between the prevalence of...
Indian Pulmonologists Release Evidence-Based Expert Review for Optimizing Nebulization in the Management of Obstructive Airway Disorders Dr. Kamal Kant Kohli20 Aug 2025 10:52 AM ISTIndia: Inhalation therapy remains a cornerstone in the treatment of obstructive, inflammatory, and infectious respiratory diseases, with inhalers...
Depression May Increase the Risk of Developing Asthma, reveals research Dr Riya Dave19 Aug 2025 9:45 PM ISTResearchers have discovered in a new study that depression can directly contribute to asthma development, indicating a possible causal connection...
Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer Ruchika Sharma19 Aug 2025 2:15 PM ISTPrinceton: SystImmune Inc., a clinical-stage biotechnology company, and Bristol Myers Squibb have announced that the U.S. Food and Drug...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
Alcohol Use Disorder and High-Risk Drinking Linked to Worse COVID-19 Outcomes Dr Riya Dave18 Aug 2025 8:45 PM ISTResearchers have determined that patients with alcohol use disorder (AUD) and excessive alcohol use are greatly at risk of severe COVID-19 outcomes,...
Precigen secures full USFDA nod for Papzimeos for adults with Recurrent Respiratory Papillomatosis Ruchika Sharma18 Aug 2025 12:30 PM ISTGermantown: Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve...
Hospitalisation in COPD Patients Linked to Sharp Rise in Cardiovascular Events and Mortality: Study Medha Baranwal17 Aug 2025 8:45 PM ISTUK: A recent study published in the International Journal of Chronic Obstructive Pulmonary Disease highlights a concerning link between...
FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis Dr. Kamal Kant Kohli15 Aug 2025 8:30 PM ISTThe FDA has approved oral brensocatib (Brinsupri) for adults and children 12+ with non-cystic fibrosis bronchiectasis. As a first-in-class reversible...
PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control Deeksha Bhandari14 Aug 2025 12:12 PM ISTA next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new milestone in adult ...
